低分子肝素钠辅治妊娠期肝内胆汁淤积症的效果

doi:10.3969/j.issn.1007-3205.2024.02.010

河北医科大学学报 ›› 2024, Vol. 45 ›› Issue (2): 178-182.doi: 10.3969/j.issn.1007-3205.2024.02.010

低分子肝素钠辅治妊娠期肝内胆汁淤积症的效果

清华大学附属北京市垂杨柳医院妇产科，北京 100022

出版日期:2024-02-25 发布日期:2024-02-06
作者简介:秦晶晶（1985-），女，河北邯郸人，清华大学附属北京市垂杨柳医院主治医师，医学硕士，从事妇产科疾病诊治研究。
基金资助:
国家重点研发计划（2016YFC1000104）

Efficacy of low molecular weight heparin sodium on intrahepatic cholestasis of pregnancy

Department of Obstetrics and Gynecology, Beijing Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing 10022， China

Online:2024-02-25 Published:2024-02-06

摘要/Abstract

摘要： 目的观察低分子肝素钠辅治妊娠期肝内胆汁淤积症（intrahepatic cholestasis of pregnancy，ICP）的效果。
方法选取本院接诊的ICP孕妇182例为研究对象，按随机数字表法分为对照组（采用熊去氧胆酸治疗，91例）和研究组（在对照组基础上加用低分子肝素钠治疗，91例）。对比分析2组孕妇的临床疗效。分析2组孕妇治疗前后的凝血酶原时间（prothrombin time，PT）、纤维蛋白原（fibrinogen，FIB）、组织型纤溶酶原激活物（tissue-type plasminogen activator，t-PA）、总胆汁酸（total biliary acid，TBA）、总胆红素（total bilirubin，TBIL）和丙氨酸转氨酶（alanine transaminase，ALT）水平。对比分析2组孕妇和新生儿的妊娠结局。
结果治疗后，研究组的总有效率显著高于对照组（P＜0.05）。治疗后，研究组的PT和t-PA高于对照组，FIB、TBA、TBIL和ALT水平低于对照组（P＜0.05）。研究组孕妇的分娩周数长于对照组（P＜0.05）。研究组的剖宫产率和产后出血率低于对照组，阴道分娩率高于对照组（均P＜0.05）。研究组新生儿5 min Apgar评分高于对照组（P＜0.05）。研究组新生儿的早产率、新生儿窒息率和宫内窘迫率低于对照组（P＜0.05）。
结论低分子肝素钠辅治ICP疗效确切，不仅可以改善孕妇凝血功能与肝功能，还可以延长妊娠时间，降低剖宫产与早产率。

关键词: 胆汁淤积, 肝内, 妊娠, 低分子肝素钠

Abstract: Objective To observe the efficacy of low molecular weight heparin sodium in the treatment of intrahepatic cholestasis of pregnancy (ICP).
Methods A total of 182 pregnant women with ICP admitted to our hospital were selected as the research subjects. They were randomly divided into control group (91 cases treated with ursodeoxycholic acid) and research group (91 cases treated with low molecular weight heparin sodium on the basis of control group). The clinical effects of two groups of pregnant women were compared and analyzed. The levels of prothrombin time (PT), fibrinogen (FIB), tissue-type plasminogen activator (t-PA), total bile acid (TBA), total bilirubin (TBIL) and alanine transaminase (ALT) were statistically analyzed before and after treatment. The pregnancy outcomes of pregnant women and newborns in two groups were compared and analyzed.
Results After treatment, the total effective rate of the research group was significantly higher than that of the control group (P＜0.05). After treatment, PT and t-PA in the research group were higher than those in the control group, and the levels of FIB, TBA, TBIL and ALT in the research group were lower than those in the control group (P＜0.05). The delivery weeks of pregnant women in the research group were longer than those in the control group (P＜0.05). The cesarean section rate and postpartum hemorrhage rate in the research group were lower than those in the control group, while the vaginal delivery rate was higher than that in the control group (all P＜0.05). The 5-min Apgar score of newborns in the research group was higher than that in the control group (P＜0.05). The premature birth rate, neonatal asphyxia rate and intrauterine distress rate in the research group were lower than those in the control group (P＜0.05).
Conclusion Low molecular weight heparin sodium is effective in the treatment of ICP. It can not only improve the coagulation function and liver function of pregnant women, but also prolong the pregnancy time, reduce the rate of cesarean section and preterm delivery.

Key words: cholestasis, intrahepatic, pregnancy, low molecular weight heparin sodium

秦晶晶, 辛德梅, 朱曼丽, 邓春霞. 低分子肝素钠辅治妊娠期肝内胆汁淤积症的效果 [J]. 河北医科大学学报, 2024, 45(2): 178-182.

QIN Jing-jing, XIN De-mei, ZHU Man-li, DENG Chun-xia. Efficacy of low molecular weight heparin sodium on intrahepatic cholestasis of pregnancy [J]. Journal of Hebei Medical University, 2024, 45(2): 178-182.

[1]	樊成芳, 马君. 甲状腺功能检测与监测血压变异系数对预测妊娠期甲状腺功能减退患者妊娠结局的临床价值 [J]. 河北医科大学学报, 2023, 44(6): 660-665,680.
[2]	尉全平, 杨建宝, 翟洪然, 侯凤香, 付晓康, 孙子梅. 孕妇糖代谢异常及维生素D缺乏对子代甲状腺功能的影响[J]. 河北医科大学学报, 2023, 44(5): 553-556,578.
[3]	王建爽, 张海静, 王雪松, 文颖, 周子敬. 两种子宫动脉栓塞方式联合超声监控下D＆C治疗CSP的疗效分析 [J]. 河北医科大学学报, 2023, 44(5): 579-583.
[4]	房军臣, 李莉, 陈新, 蒲伟丛, 马莉, 邱向利. 高危早产儿肠外营养相关性胆汁淤积的危险因素及转归分析 [J]. 河北医科大学学报, 2023, 44(4): 444-449.
[5]	袁二伟, 朱雷, 许津莉, 郭华贤. 妊娠期糖尿病产妇脐血FTM、AGE水平与新生儿低血糖的相关性研究 [J]. 河北医科大学学报, 2023, 44(11): 1312-1316.
[6]	王亚宁, 徐倩（综述）, 王芳, 张方华（审校）. 妊娠期亚临床甲状腺功能减退相关危险因素研究进展 [J]. 河北医科大学学报, 2023, 44(11): 1344-1348.
[7]	曹荣来（综述）, 朱亮（审校）. 妊娠期胆胰疾病的ERCP诊疗进展 [J]. 河北医科大学学报, 2023, 44(10): 1227-1231.
[8]	邵婕, 杨美芳, 张秀. 妊娠期糖尿病患者血清GLP-1及胎盘组织中IGF-1R与新生儿结局的关系 [J]. 河北医科大学学报, 2022, 43(9): 1042-1046.
[9]	韩雁雁, 邱锐琴, 乔木, 姚文秀, 张洁. GDM母亲婴儿脐血脂联素与糖脂代谢、胎儿生长发育的关系 [J]. 河北医科大学学报, 2022, 43(7): 806-810.
[10]	杨志芬, 王春洋, 郑芮. 2021年《ISIDOG备孕期、妊娠期和哺乳期接种COVID-19疫苗指南》解读[J]. 河北医科大学学报, 2022, 43(2): 125-129,172.
[11]	李澎涛, 殷晨星, 王娜, 邢鹏, 孟娜娜, 郭战坤. 不同发育阶段、不同质量囊胚冷冻复苏移植周期妊娠结局分析[J]. 河北医科大学学报, 2022, 43(2): 166-172.
[12]	张筱, 闫璐, 李连心, 于淼, 张敬坤, 杜彦芳. 剖宫产瘢痕部位妊娠预后风险量化预评分系统的建立 [J]. 河北医科大学学报, 2022, 43(12): 1439-1444,1448.
[13]	李洪梅, 石少凤, 肖娴静. 阴道超声对输卵管妊娠的诊断价值及甲氨蝶呤与腹腔镜治疗效果比较 [J]. 河北医科大学学报, 2022, 43(11): 1302-1305.
[14]	董亚青, 高志敏, 徐然, 陈立芳, 袁静, 王明荣. 全自动胎儿肺部超声分析预测妊娠晚期胎儿肺成熟度的研究 [J]. 河北医科大学学报, 2022, 43(10): 1192-1196.
[15]	朱博雅, 江乾, 赵静云, 乜照燕, 甄秀丽, 吕翠婷. 子宫结合带厚度及形态对子宫腺肌病患者行冻胚移植临床结局的影响[J]. 河北医科大学学报, 2022, 43(1): 49-53.

低分子肝素钠辅治妊娠期肝内胆汁淤积症的效果

Efficacy of low molecular weight heparin sodium on intrahepatic cholestasis of pregnancy

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价